Phosphotyrosine signaling: evolving a new cellular communication system - PubMed (original) (raw)
Phosphotyrosine signaling: evolving a new cellular communication system
Wendell A Lim et al. Cell. 2010.
Abstract
Tyrosine phosphorylation controls many cellular functions. Yet the three-part toolkit that regulates phosphotyrosine signaling-tyrosine kinases, phosphotyrosine phosphatases, and Src Homology 2 (SH2) domains-is a relatively new innovation. Genomic analyses reveal how this revolutionary signaling system may have originated and why it rapidly became critical to metazoans.
Copyright 2010 Elsevier Inc. All rights reserved.
Figures
Figure 1. The Writer, Reader, Eraser pTyr Toolkit
(A) In pTyr signaling, the tyrosine kinase (TyrK), Src Homology 2 (SH2), and phosphotyrosine phosphatase (PTP) domains form a highly interdependent signaling platform. This platform serves as the writer, reader, and eraser modules, respectively, for processing pTyr marks. (B) Components of pTyr signaling can be used to build complex circuits. For example, recruitment of an SH2-TyrK protein to an initiating pTyr site can lead to amplification of tyrosine phosphorylation through a positive feedback loop.
Figure 2. Evolution of pTyr signaling
Shown is a possible path for the emergence of phosphotyrosine (pTyr) signaling. . We postulate three successive stages, each represented by what is observed in a modern organism. The thickness of the tree reflects the approximate degree of usage of pTyr signaling (thicker lines means more usage). Stage 1 (exemplified by the budding yeast Saccharomyces cerevisiae) reflects the situation in early eukaryotes, in which PTPs emerged but were limited in number and complexity. They were most likely used to reverse or process sporadic cross-phosphorylation of tyrosine residues by Ser/Thr kinases. S. cerevisiae has <5 PTP proteins and no functional SH2 or TyrK domains. Stage 2 reflects systems in which functional SH2 domains emerged that were able to bind to pTyr motifs. Together with Ser/Thr kinases with increased cross-reactivity for Tyr (such as tyrosine kinase-like or dual specificity Ser/Thr kinases), these systems may reflect the most primitive of pTyr writer/reader/eraser systems. However, the lack of a dedicated Tyr kinase may have limited the utility and expansion of this toolkit. This stage is potentially represented by the slime mold, Dictyostelium discoideum. Stage 3 reflects systems that evolved after the emergence of the modern TyrK domain. We postulate that the full writer/reader/eraser system was of so much greater utility, that its use expanded dramatically. This likely resulted in many more proteins in these families, as well as much more complex, multi-domain architectures than those seen in the earlier stages. This stage is represented by both the multicellular metazoan and unicellular choanoflagellate lineages.
Similar articles
- The human phosphotyrosine signaling network: evolution and hotspots of hijacking in cancer.
Li L, Tibiche C, Fu C, Kaneko T, Moran MF, Schiller MR, Li SS, Wang E. Li L, et al. Genome Res. 2012 Jul;22(7):1222-30. doi: 10.1101/gr.128819.111. Epub 2011 Dec 22. Genome Res. 2012. PMID: 22194470 Free PMC article. - Classification and Lineage Tracing of SH2 Domains Throughout Eukaryotes.
Liu BA. Liu BA. Methods Mol Biol. 2017;1555:59-75. doi: 10.1007/978-1-4939-6762-9_4. Methods Mol Biol. 2017. PMID: 28092027 - The SH2 domain-containing proteins in 21 species establish the provenance and scope of phosphotyrosine signaling in eukaryotes.
Liu BA, Shah E, Jablonowski K, Stergachis A, Engelmann B, Nash PD. Liu BA, et al. Sci Signal. 2011 Dec 6;4(202):ra83. doi: 10.1126/scisignal.2002105. Sci Signal. 2011. PMID: 22155787 Free PMC article. - Profiling the global tyrosine phosphorylation state.
Machida K, Mayer BJ, Nollau P. Machida K, et al. Mol Cell Proteomics. 2003 Apr;2(4):215-33. doi: 10.1074/mcp.R300002-MCP200. Epub 2003 May 17. Mol Cell Proteomics. 2003. PMID: 12754303 Review. - Evolution of SH2 domains and phosphotyrosine signalling networks.
Liu BA, Nash PD. Liu BA, et al. Philos Trans R Soc Lond B Biol Sci. 2012 Sep 19;367(1602):2556-73. doi: 10.1098/rstb.2012.0107. Philos Trans R Soc Lond B Biol Sci. 2012. PMID: 22889907 Free PMC article. Review.
Cited by
- The application of modular protein domains in proteomics.
Jadwin JA, Ogiue-Ikeda M, Machida K. Jadwin JA, et al. FEBS Lett. 2012 Aug 14;586(17):2586-96. doi: 10.1016/j.febslet.2012.04.019. Epub 2012 Apr 21. FEBS Lett. 2012. PMID: 22710164 Free PMC article. Review. - Navigating cancer network attractors for tumor-specific therapy.
Creixell P, Schoof EM, Erler JT, Linding R. Creixell P, et al. Nat Biotechnol. 2012 Sep;30(9):842-8. doi: 10.1038/nbt.2345. Nat Biotechnol. 2012. PMID: 22965061 - Temperature sensitivities of metazoan and pre-metazoan Src kinases.
Miller WT. Miller WT. Biochem Biophys Rep. 2020 Jun 10;23:100775. doi: 10.1016/j.bbrep.2020.100775. eCollection 2020 Sep. Biochem Biophys Rep. 2020. PMID: 32566764 Free PMC article. - The I7L protein of African swine fever virus is involved in viral pathogenicity by antagonizing the IFN-γ-triggered JAK-STAT signaling pathway through inhibiting the phosphorylation of STAT1.
Li M, Liu X, Peng D, Yao M, Wang T, Wang Y, Cao H, Wang Y, Dai J, Luo R, Deng H, Li J, Luo Y, Li Y, Sun Y, Li S, Qiu HJ, Li LF. Li M, et al. PLoS Pathog. 2024 Sep 26;20(9):e1012576. doi: 10.1371/journal.ppat.1012576. eCollection 2024 Sep. PLoS Pathog. 2024. PMID: 39325821 Free PMC article. - The human phosphotyrosine signaling network: evolution and hotspots of hijacking in cancer.
Li L, Tibiche C, Fu C, Kaneko T, Moran MF, Schiller MR, Li SS, Wang E. Li L, et al. Genome Res. 2012 Jul;22(7):1222-30. doi: 10.1101/gr.128819.111. Epub 2011 Dec 22. Genome Res. 2012. PMID: 22194470 Free PMC article.
References
- Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. Cell. 2004;117(6):699–711. - PubMed
- Alwayn V. Optical Network Design and Implementation. Cisco Press; 2004.
- Bhattacharyya RP, Reményi A, Yeh BJ, Lim WA. Annu Rev Biochem. 2006;75:655–80. - PubMed
- Dengl S, Mayer A, Sun M, Cramer P. J Mol Biol. 2009;389(1):211–25. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 GM062583-08/GM/NIGMS NIH HHS/United States
- P50 GM081879-01A2/GM/NIGMS NIH HHS/United States
- PN2 EY016546-06/EY/NEI NIH HHS/United States
- GM081879/GM/NIGMS NIH HHS/United States
- GM55040/GM/NIGMS NIH HHS/United States
- P50 GM081879/GM/NIGMS NIH HHS/United States
- R01 GM055040/GM/NIGMS NIH HHS/United States
- GM62583/GM/NIGMS NIH HHS/United States
- PN2 EY016546/EY/NEI NIH HHS/United States
- R01 GM055040-12/GM/NIGMS NIH HHS/United States
- EY016546/EY/NEI NIH HHS/United States
- -MOP-6849/CAPMC/ CIHR/Canada
- HHMI/Howard Hughes Medical Institute/United States
- PN1 EY016546/EY/NEI NIH HHS/United States
- R01 GM062583/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous